Increasing placebo response in antipsychotic trials: a clinical perspective.
about
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.The placebo effect and its clinical associations in gambling disorderAre molecular scanners going to make double-blind placebo-controlled trials impossible?
P2860
Increasing placebo response in antipsychotic trials: a clinical perspective.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Increasing placebo response in antipsychotic trials: a clinical perspective.
@en
type
label
Increasing placebo response in antipsychotic trials: a clinical perspective.
@en
prefLabel
Increasing placebo response in antipsychotic trials: a clinical perspective.
@en
P2860
P50
P356
P1476
Increasing placebo response in antipsychotic trials: a clinical perspective
@en
P2860
P356
10.1136/EB-2015-102098
P407
P577
2015-06-29T00:00:00Z